New cancer warnings added to eczema creams

Eczema creams sold by Novartis AG and Astellas Pharma Inc. will come with a “black-box” warning about a possible risk of cancer from the prescription treatments, U.S. regulators said on Thursday.

A black-box warning is the strongest type used in the United States for prescription drugs.

The new warnings apply to Novartis AG’s drug Elidel and Astellas Pharma’s Protopic.

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

Cell-associated HIV mucosal transmission: The neglected pathway   Study ties breathing problems, asthma to bone loss   Slowing the allergic march   Special infant formula may not prevent allergies   Protein associated with allergic response causes airway changes in asthma patients   Features of the metabolic syndrome common in persons with psoriasis   Landmark Study Shows Suboptimal Asthma Care   Asthma and Eczema Sufferers Have a Lower Risk of Developing a Cancer   Does breastfeeding protect against asthma?   Sleep apnea as common as asthma in German kids   Rates of food sensitivity vary by country   Association Discovered Between Eczema in Early Childhood and Psychological Problems